Alison Crawford
11Patents
4h-index
19Co-inventors
49Inventor score
Filing activity: Jul 29, 2016 → Sep 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10772972B2 | Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof | Chemistry; Metallurgy | 38 | Active |
| US10738130B2 | Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof | Physics | 38 | Active |
| US10179819B2 | Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11155633B2 | Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10941208B2 | Anti-MUC16 antibodies | Physics | 1 | Active |
| US12091460B2 | Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation | Chemistry; Metallurgy | 0 | Active |
| US11453721B2 | Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11633501B2 | Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11485793B2 | Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof | Physics | 0 | Active |
| US11254752B2 | Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12344677B2 | Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.